New: companion diagnostics

Learn more

Latest news

White paper: quality control of biologics – precision safety through long-read sequencing

Read our white paper on long-read sequencing for biologics QC, with case studies showcasing genetic variant accuracy.

Companion Diagnostics: Importance, Technologies, and Regulatory Landscape

Learn about the key differences between IVD and LDT, the impact of the new IVDR, and the promising role of epigenetics a ...

Elevate your genomic discoveries with Nanopore Sequencing

What is Nanopore Sequencing? Nanopore sequencing is a third-generation sequencing technology (TGS) that enables the real ...

The incredible power of RNA sequencing

What is RNA sequencing? RNA sequencing (RNA-seq) is a powerful technique used to analyze the transcriptome, which refers ...

OHMX.bio PARTNERS AT THE WORLD CB-CDx SUMMIT in BOSTON

This year we’re partnering at the 13th Clinical Biomarkers & CDx World 2023 conference in Boston, US. Our ...

EXCITING NEWS: renewed ISO-9001 and ISO-27001 certification!

📣 Exciting News! 🏆 We are thrilled to announce that we have once again achieved the ISO-9001 and ISO-27001 certifi ...

OHMX.bio is off to London for the CB CDx meeting

This year we’re sponsoring the 13th Clinical Biomarkers & CDx Europe 2023 conference. Our CSO and Co-founder, ...

OHMX.bio is branching out: CDx on demand

To respond to growing demand from the biotech and the diagnostic field for partnerships with expertise in diagnostic ass ...

OHMX.bio reached a new milestone this year. We are ISO 9001:2015 certified!

This certification provides our customers with the assurance that they are working with an organization that is committe ...

OHMX.bio was featured in Kanaal Z – Canal Z.

During this interview, our CSO, Gerben Menschaert, and business developer, Zarel L. Martinez, explain: Who we ...

Upcoming events

OHMX.bio PARTNERS AT THE WORLD CB-CDx SUMMIT in BOSTON

This year we’re partnering at the 13th Clinical Biomarkers & CDx World 2023 conference in Boston, US. Our ...

OHMX.bio is off to London for the CB CDx meeting

This year we’re sponsoring the 13th Clinical Biomarkers & CDx Europe 2023 conference. Our CSO and Co-founder, ...

Nanopore day 2022: OHMX.bio took home an award

During the Nanopore Day 2022 in Ghent, our Iuliana Vintea, VLAIO Baekeland PhD fellow of OHMX.bio, gave a presentation o ...

OHMX.bio is presenting at Life-on-chip event

Our CSO and Co-founder, Gerben Menschaert, is presenting at the “Life-on-chip” virtual conference in th ...

Swiss BioTech Day 2021: April 20, Basel (Swiss)

Karine Clauwaert, director Business Development and Gerben Menschaert, CSO, will be attending the Swiss biotech day in 2 ...

Knowledge for Growth 2020: September 10, Ghent (Belgium)

OHMX.bio its team members, Karine Clauwaert and Gerben Menschaert will be attending the Flanders.bio Knowledge for growt ...

Innovation For Health 2021: April 16-17, Rotterdam, (The Netherlands)

OHMX.bio will be attending Innovation for Health in 2021 Innovation for Health is the leading conference for k ...

It seems that you haven't connected with your Twitter account